| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 02/25/2004 | CN1478078A Nitrogenous aromatic ring compounds |
| 02/25/2004 | CN1477963A Organic compounds |
| 02/25/2004 | CN1139575C Method for preparing quinoline-5,8-diones |
| 02/24/2004 | US6696494 α-hydroxyarylbutanamine inhibitors of aspartyl protease |
| 02/24/2004 | US6696467 Quinoline derivatives |
| 02/24/2004 | US6696459 Using high affinity, high selectivity quinoline derivativesw |
| 02/24/2004 | US6696451 Dihydropyrimidines |
| 02/24/2004 | US6696445 Neuropeptide y receptor antagonists comprising heterocyclic nitrogen compounds and/or prodrugs used for prophylaxis of eating and cardiovascular disorders |
| 02/24/2004 | US6696442 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 02/24/2004 | US6696434 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 02/24/2004 | CA2208141C Fungicidal mixture |
| 02/19/2004 | WO2004014871A1 Vanilloid receptor ligands and their use in treatments |
| 02/19/2004 | WO2004014867A2 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 02/19/2004 | WO2004014861A1 4-substituted-quinoline-8-carboxylic amide derivatives and pharmacologically acceptable addition salts thereof |
| 02/19/2004 | WO2004014860A2 Fused heterocyclic compounds as peptidase inhibitors |
| 02/19/2004 | WO2004014851A2 Tyrosine kinase inhibitors |
| 02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/19/2004 | WO2004014842A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/19/2004 | WO2004014825A1 Cannabinoid receptor ligands |
| 02/19/2004 | WO2004014389A1 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014381A2 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 02/19/2004 | WO2004014377A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014369A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/19/2004 | WO2004014361A1 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 02/19/2004 | WO2003065989A3 (oxime)carbamoyl fatty acid amide hydrolase inhibitors |
| 02/19/2004 | US20040034228 Contacting N-(4-methoxyphenyl)-3-chloropropionamide with Lewis acid catalyst in a diluent (dimethylsulfoxide, amine and N,N-disubstituted amides), to cyclize and demethylate to form lewis acid salt and decomposing the Lewis acid salt |
| 02/19/2004 | US20040034227 Reacting a quinoline-3-carboxylic acid ester derivative with an aniline derivative in a alkane or cycloalkane solvent |
| 02/19/2004 | US20040034104 2,2-Diphenylbutanamide derivatives and medicines containing the same |
| 02/19/2004 | US20040034069 Nitrogen-containing compounds and their use as glycine transport inhibitors |
| 02/19/2004 | US20040034032 Quinoline and quinazoline compounds useful in therapy |
| 02/19/2004 | US20040034011 Administering to a mammal a napthalene derivative containing at least two hydroxy groups at ortho position to one another, for the treatment of disorders caused by catechol-O-methyltransferase enzyme |
| 02/19/2004 | CA2494827A1 Cannabinoid receptor ligands |
| 02/19/2004 | CA2494298A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/19/2004 | CA2494048A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/18/2004 | EP1389611A1 20-hydroxyeicosatetraenoic acid production inhibitors |
| 02/18/2004 | EP1389460A1 Cxcr4-antagonistic drugs comprising nitrogen-containing compound |
| 02/18/2004 | EP1389189A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 02/18/2004 | EP1389185A2 Aminoalcohol derivatives |
| 02/18/2004 | EP1389110A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 02/18/2004 | EP1178958B1 N-cyanomethyl amides as protease inhibitors |
| 02/18/2004 | CN1476438A Fused heteroaromatic glucokinase activators |
| 02/18/2004 | CN1476435A Fluorinated quinolones as antimitotic and antitumor agents |
| 02/18/2004 | CN1476424A 萘衍生物 Naphthalene Derivatives |
| 02/18/2004 | CN1138774C Substituted 6,6-hetero-bicyclic derivatives |
| 02/18/2004 | CN1138760C Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 02/18/2004 | CN1138546C Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 02/17/2004 | US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter |
| 02/17/2004 | US6693197 Process for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino- [2,3-f] quinoline |
| 02/17/2004 | US6693105 Using xanthinyl derivatives to reduce treatment induced toxicity; inhibiting cellular signaling through second messenger pathway; reducing cellular level of nonarachi-donate phosphatidic acid and diacylglycerol |
| 02/17/2004 | US6693103 1,2,3,4-tetrahydro-2-thioxo-quinolinyl and 1,2,3,4-tetrahydro-2-oxo-quinolinyl derivatives as progesterone receptor modulators |
| 02/17/2004 | US6693099 Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| 02/17/2004 | US6693098 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
| 02/12/2004 | WO2004013103A2 Process for preparing quinolone antibiotic intermediates |
| 02/12/2004 | WO2004013094A2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/12/2004 | WO2004012739A1 Novel crystalline forms of gatifloxacin |
| 02/12/2004 | WO2004012663A2 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme |
| 02/12/2004 | WO2003090672A3 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 02/12/2004 | WO2003049702A3 Vanilloid receptor ligands and their use in treatments |
| 02/12/2004 | WO2002100344A3 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 02/12/2004 | US20040030131 Central nervous system disorders |
| 02/12/2004 | US20040030129 NF-kappaB inhibitor comprising phenylmethyl benzoquinone as an active ingredient |
| 02/12/2004 | US20040029928 Tumor necrosis factor alpha-converting enzyme inhibitor; rheumatic diseases; antiarthritic agents; infections; autoimmune diseases; antidiabetic agents |
| 02/12/2004 | US20040029913 Halogenated selective androgen receptor modulators and methods of use thereof |
| 02/12/2004 | US20040029898 Anticancer agents |
| 02/12/2004 | US20040029889 Bone disorders; antiarrhythmia agents; cardiovascular disorders |
| 02/12/2004 | US20040029871 Pharmaceutical compounds for treating copd |
| 02/12/2004 | US20040029862 Alzheimer's disease |
| 02/12/2004 | US20040029814 Cathepins inhibitor; antiinflammatory agents; antiarthritic agents |
| 02/12/2004 | DE19538404B4 Difluorchinolin-Derivate und diese enthaltenden Flüssigkristallmischungen sowie Schalt- und/oder Anzeigevorrichtung Difluoroquinoline derivatives, and liquid crystal mixtures containing them, as well as switching and / or display device |
| 02/12/2004 | CA2494518A1 Novel crystalline forms of gatifloxacin |
| 02/12/2004 | CA2494404A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/11/2004 | EP1388535A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/11/2004 | EP1388341A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/11/2004 | EP1387845A2 PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-(2,3-f) QUINOLINE |
| 02/11/2004 | EP1387830A1 Novel 4-anilinoquinoline-3-carboxamides |
| 02/11/2004 | EP1387687A2 Novel use |
| 02/11/2004 | EP1387683A1 Novel salt and crystalline forms of (2r)-anti-5-3-(4-(10,11-difluoromethanodibenzosuber-5-yl)piperazin-1-yl)-2-hydroxypropoxy quinoline |
| 02/11/2004 | EP1387612A1 Pyridinyl fused bicyclic amide as fungicides |
| 02/11/2004 | CN1474803A Novel amide derivatives and medicinal use thereof |
| 02/11/2004 | CN1137890C 8-alkoxyquinolone carboxylic acid with excellent stability and process for producing same |
| 02/11/2004 | CN1137883C Aromatic carboxylic acid ester, its production and use of same as medicaments |
| 02/10/2004 | US6689897 Intermediates of CETP inhibitors |
| 02/10/2004 | US6689886 Treatment of inflammation and other immune disorders |
| 02/10/2004 | US6689791 Carboxylated heterocyclic compounds and methods of synthesis |
| 02/10/2004 | US6689772 Antineoplastic agents; osteoporosis; polycystic kidney disease; antiviral agents |
| 02/10/2004 | US6689771 Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase |
| 02/05/2004 | WO2004011436A1 Quinoline derivatives and their use as mycobacterial inhibitors |
| 02/05/2004 | WO2004010761A2 Pesticidal cyanine dye derivatives |
| 02/05/2004 | WO2003080608A3 Quinoline and aza-indole derivatives and their use as 5-ht6 ligands |
| 02/05/2004 | WO2003080580A3 Quinoline derivatives and their use as 5-ht6 ligands |
| 02/05/2004 | US20040024210 New compounds |
| 02/05/2004 | US20040024209 Drugs such as 4-(3-Bromo-4-fluorobenzyl)morpholine used as viricides against herpes viruses |
| 02/05/2004 | US20040024066 E.g., N-(2-(Benzo(b)thiophen-5-ylmethanesulfonyl)-1-(3,4-dichloro- phenyl)- ethyl)-N-hydroxyformamide; gene expression inhibitors of s-CD23; autoimmune disease; antiallergens; matrix metalloprotease enzyme inhibitors |
| 02/05/2004 | US20040023999 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/05/2004 | US20040023290 Novel therapeutic agents that modulate enzymatic processes |
| 02/04/2004 | EP1386914A1 Halogenated quinoline derivatives and ectoparasite controllers |
| 02/04/2004 | EP1386608A1 Remedial agent for glomerular disease |
| 02/04/2004 | EP1385839A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/04/2004 | EP1385820A1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |